GlassScriptPhysician profile
Stuart W Weisman
NPI 1922023787
$2,534.55
in general payments reported to CMS, 2019-2025
20 companies · $448 in 2025
The $448 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2020: $65.14 · 2021: $254 · 2022: $408 · 2023: $572 · 2024: $557 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,578.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,577.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $554.69 | 2022-2025 | Durysta, Lumigan, Alphagan P |
| Oyster Point Pharma, INC. | $324.74 | 2022-2025 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $310.01 | 2019-2023 | |
| Alcon Vision LLC | $192.04 | 2022-2025 | Rocklatan, Tryptyr |
| Allergan, INC. | $181.95 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $159.69 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $158.12 | 2019-2025 | Cequa |
| Amgen INC. | $122.24 | 2024-2025 | Tepezza |
| Mallinckrodt Hospital Products INC. | $118.81 | 2021-2023 | Acthar |
| Bausch & Lomb Americas INC. | $118.30 | 2023-2025 | Miebo, Vyzulta, Prolensa |
| Horizon Therapeutics Plc | $51.08 | 2022-2023 | Tepezza |
| Kala Pharmaceuticals, INC. | $45.91 | 2020 | |
| Carl Zeiss Meditec USA, INC. | $37.45 | 2022 | |
| Rxsight INC | $37.42 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| Aerie Pharmaceuticals, INC. | $24.23 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $24.04 | 2021 | |
| Dompe US, INC. | $23.07 | 2022 | |
| Rayner Intraocular Lenses Limited | $18.48 | 2023 | Omidria, Rayone Aspheric, Rayone Emv |
| Merz Pharmaceuticals, LLC | $18.42 | 2021 | |
| Thea Pharma INC. | $13.86 | 2024 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Weisman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.